OWENS & MINOR INC (OMI) Stock Fundamental Analysis
NYSE:OMI - New York Stock Exchange, Inc. - US6907321029 - Common Stock - Currency: USD
We assign a fundamental rating of 4 out of 10 to OMI. OMI was compared to 105 industry peers in the Health Care Providers & Services industry. There are concerns on the financial health of OMI while its profitability can be described as average. OMI scores decently on growth, while it is valued quite cheap. This could make an interesting combination.
1. Profitability
1.1 Basic Checks
In the past year OMI was profitable.
In the past year OMI had a positive cash flow from operations.
In multiple years OMI reported negative net income over the last 5 years.
In the past 5 years OMI always reported a positive cash flow from operatings.
1.2 Ratios
OMI has a Return On Assets of -7.79%. This is in the lower half of the industry: OMI underperforms 72.38% of its industry peers.
OMI has a Return On Equity of -64.17%. This is in the lower half of the industry: OMI underperforms 73.33% of its industry peers.
OMI has a Return On Invested Capital of 6.56%. This is in the better half of the industry: OMI outperforms 67.62% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for OMI is below the industry average of 8.81%.
The 3 year average ROIC (6.20%) for OMI is below the current ROIC(6.56%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -7.79% | ||
| ROE | -64.17% | ||
| ROIC | 6.56% |
ROA(3y)-2.73%
ROA(5y)-0.2%
ROE(3y)-22.09%
ROE(5y)-7.69%
ROIC(3y)6.2%
ROIC(5y)8.54%
1.3 Margins
With a Operating Margin value of 2.16%, OMI perfoms like the industry average, outperforming 49.52% of the companies in the same industry.
OMI's Operating Margin has improved in the last couple of years.
The Gross Margin of OMI (20.74%) is comparable to the rest of the industry.
OMI's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.16% | ||
| PM (TTM) | N/A | ||
| GM | 20.74% |
OM growth 3Y-19.34%
OM growth 5Y14%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.28%
GM growth 5Y11.1%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so OMI is destroying value.
OMI has more shares outstanding than it did 1 year ago.
OMI has more shares outstanding than it did 5 years ago.
OMI has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 2.58 indicates that OMI is not a great score, but indicates only limited risk for bankruptcy at the moment.
OMI has a Altman-Z score (2.58) which is comparable to the rest of the industry.
OMI has a Debt/Equity ratio of 3.20. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of OMI (3.20) is worse than 80.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 3.2 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 2.58 |
ROIC/WACC0.84
WACC7.84%
2.3 Liquidity
OMI has a Current Ratio of 1.08. This is a normal value and indicates that OMI is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.08, OMI is doing worse than 72.38% of the companies in the same industry.
A Quick Ratio of 0.47 indicates that OMI may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.47, OMI is doing worse than 89.52% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.08 | ||
| Quick Ratio | 0.47 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 11.76% over the past year.
Measured over the past years, OMI shows a very strong growth in Earnings Per Share. The EPS has been growing by 22.10% on average per year.
Looking at the last year, OMI shows a small growth in Revenue. The Revenue has grown by 3.55% in the last year.
Measured over the past years, OMI shows a small growth in Revenue. The Revenue has been growing by 3.04% on average per year.
EPS 1Y (TTM)11.76%
EPS 3Y-28.62%
EPS 5Y22.1%
EPS Q2Q%-20.29%
Revenue 1Y (TTM)3.55%
Revenue growth 3Y3.03%
Revenue growth 5Y3.04%
Sales Q2Q%1.5%
3.2 Future
OMI is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.25% yearly.
OMI is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.63% yearly.
EPS Next Y15.01%
EPS Next 2Y17.31%
EPS Next 3Y17.35%
EPS Next 5Y14.25%
Revenue Next Year2.44%
Revenue Next 2Y2.44%
Revenue Next 3Y2.63%
Revenue Next 5YN/A
3.3 Evolution
Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
OMI is valuated cheaply with a Price/Earnings ratio of 4.57.
Based on the Price/Earnings ratio, OMI is valued cheaper than 99.05% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 28.79, OMI is valued rather cheaply.
The Price/Forward Earnings ratio is 3.98, which indicates a rather cheap valuation of OMI.
99.05% of the companies in the same industry are more expensive than OMI, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 21.38. OMI is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 4.57 | ||
| Fwd PE | 3.98 |
4.2 Price Multiples
OMI's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. OMI is cheaper than 93.33% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 4.73 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as OMI's earnings are expected to grow with 17.35% in the coming years.
PEG (NY)0.3
PEG (5Y)0.21
EPS Next 2Y17.31%
EPS Next 3Y17.35%
5. Dividend
5.1 Amount
No dividends for OMI!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
6.95
-0.02 (-0.29%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners101.93%
Inst Owner Change0.09%
Ins Owners2.19%
Ins Owner Change17.77%
Market Cap536.89M
Analysts48.33
Price Target11.55 (66.19%)
Short Float %4.95%
Short Ratio1.87
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)2.73%
Min EPS beat(2)0.62%
Max EPS beat(2)4.84%
EPS beat(4)4
Avg EPS beat(4)4.84%
Min EPS beat(4)0.62%
Max EPS beat(4)8.73%
EPS beat(8)8
Avg EPS beat(8)24.17%
EPS beat(12)10
Avg EPS beat(12)15.02%
EPS beat(16)14
Avg EPS beat(16)18.07%
Revenue beat(2)1
Avg Revenue beat(2)-0.03%
Min Revenue beat(2)-0.59%
Max Revenue beat(2)0.52%
Revenue beat(4)1
Avg Revenue beat(4)-0.26%
Min Revenue beat(4)-0.88%
Max Revenue beat(4)0.52%
Revenue beat(8)3
Avg Revenue beat(8)0.36%
Revenue beat(12)6
Avg Revenue beat(12)0.76%
Revenue beat(16)8
Avg Revenue beat(16)0.43%
PT rev (1m)-6.96%
PT rev (3m)-30.69%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-21.69%
EPS NY rev (1m)-3.06%
EPS NY rev (3m)-6.81%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.14%
Revenue NY rev (1m)-0.22%
Revenue NY rev (3m)-1.69%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 4.57 | ||
| Fwd PE | 3.98 | ||
| P/S | 0.05 | ||
| P/FCF | N/A | ||
| P/OCF | 3.32 | ||
| P/B | 0.95 | ||
| P/tB | N/A | ||
| EV/EBITDA | 4.73 |
EPS(TTM)1.52
EY21.87%
EPS(NY)1.75
Fwd EY25.15%
FCF(TTM)-0.86
FCFYN/A
OCF(TTM)2.09
OCFY30.08%
SpS138.52
BVpS7.32
TBVpS-13.78
PEG (NY)0.3
PEG (5Y)0.21
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -7.79% | ||
| ROE | -64.17% | ||
| ROCE | 8.3% | ||
| ROIC | 6.56% | ||
| ROICexc | 6.68% | ||
| ROICexgc | 16.55% | ||
| OM | 2.16% | ||
| PM (TTM) | N/A | ||
| GM | 20.74% | ||
| FCFM | N/A |
ROA(3y)-2.73%
ROA(5y)-0.2%
ROE(3y)-22.09%
ROE(5y)-7.69%
ROIC(3y)6.2%
ROIC(5y)8.54%
ROICexc(3y)6.48%
ROICexc(5y)8.87%
ROICexgc(3y)17.5%
ROICexgc(5y)17.65%
ROCE(3y)7.85%
ROCE(5y)10.81%
ROICexcg growth 3Y-7.18%
ROICexcg growth 5Y24.61%
ROICexc growth 3Y-23.44%
ROICexc growth 5Y12.07%
OM growth 3Y-19.34%
OM growth 5Y14%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.28%
GM growth 5Y11.1%
F-Score4
Asset Turnover2.3
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 3.2 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 3.65 | ||
| Cap/Depr | 86.17% | ||
| Cap/Sales | 2.13% | ||
| Interest Coverage | 1.63 | ||
| Cash Conversion | 32.57% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.08 | ||
| Quick Ratio | 0.47 | ||
| Altman-Z | 2.58 |
F-Score4
WACC7.84%
ROIC/WACC0.84
Cap/Depr(3y)77.12%
Cap/Depr(5y)69.93%
Cap/Sales(3y)1.94%
Cap/Sales(5y)1.4%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)11.76%
EPS 3Y-28.62%
EPS 5Y22.1%
EPS Q2Q%-20.29%
EPS Next Y15.01%
EPS Next 2Y17.31%
EPS Next 3Y17.35%
EPS Next 5Y14.25%
Revenue 1Y (TTM)3.55%
Revenue growth 3Y3.03%
Revenue growth 5Y3.04%
Sales Q2Q%1.5%
Revenue Next Year2.44%
Revenue Next 2Y2.44%
Revenue Next 3Y2.63%
Revenue Next 5YN/A
EBIT growth 1Y-28.28%
EBIT growth 3Y-16.89%
EBIT growth 5Y17.47%
EBIT Next Year85.57%
EBIT Next 3Y28.73%
EBIT Next 5YN/A
FCF growth 1Y-112.51%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-78.2%
OCF growth 3Y9.15%
OCF growth 5Y-0.56%